Accretive Health
AH
AH was delisted on the 14th of March, 2014.
6 hedge funds and large institutions have $23.4M invested in Accretive Health in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
33% more capital invested
Capital invested by funds: $17.7M → $23.4M (+$5.75M)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GMT Capital
Atlanta,
Georgia
|
+$4.09M |
| 2 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$2.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$111K |
| 2 |
Neuberger Berman Group
New York
|
-$90.3K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$384 |
AH Hedge Fund Activity: Q2 2015 in Review
6 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Accretive Health (AH) for Q2 2015, worth a combined $23.4M — up 33% from $17.7M a quarter earlier.
Fund positioning in AH was balanced in Q2 2015: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was GMT Capital, opening a new position worth an estimated $4.09M. The largest seller was Northern Trust, exiting entirely with an estimated $111K sold.
- 6 institutional investors held Accretive Health (AH) as of Q2 2015, unchanged from Q1 2015.
- Funds reported $23.4M of Accretive Health stock for Q2 2015, up 33% quarter-over-quarter.
- 1 fund opened new Accretive Health positions in Q2 2015 and 1 closed out, a net change of 0 holders.
- The largest Accretive Health buyer in Q2 2015 was GMT Capital, an estimated $4.09M added.
- The largest Accretive Health seller in Q2 2015 was Northern Trust, an estimated $111K sold.
Based on aggregated 13F filings for Q2 2015.